Voyager Therapeutics
A biotechnology company dedicated to leveraging human genetics to modify the course of – and ultimately cure – neurological diseases.
Last updated September 1, 2026
AI crawler reads
No AI crawler has read this profile since Oct 28, 2026.
Overview
Voyager Therapeutics is a biotechnology company dedicated to leveraging the power of human genetics to modify the course of – and ultimately cure – neurological diseases. Its pipeline includes genetic medicines for Alzheimer's disease, amyotrophic lateral sclerosis (ALS), Parkinson's disease, and multiple other diseases of the central nervous system. The company is publicly traded on Nasdaq under the ticker VYGR.
History
Voyager Therapeutics is a biotechnology company dedicated to leveraging the power of human genetics to modify the course of – and ultimately cure – neurological diseases. Its pipeline includes genetic medicines for Alzheimer's disease, amyotrophic lateral sclerosis (ALS), Parkinson's disease, and multiple other diseases of the central nervous system. The company is publicly traded on Nasdaq under the ticker VYGR.
Sources2 sources
Cite this profile: Cite the canonical profile. /brand-wiki/voyager-therapeutics · Editorial policy · How profiles are compiled